世界の豚丹毒ワクチン市場インサイト・予測（～2027年）

• 英文タイトル：Global Swine Erysipelas Vaccine Market Insights and Forecast to 2027

• レポートコード：QY2108PAL4044 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は豚丹毒ワクチンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。豚丹毒ワクチンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（活性、非活性）、用途別市場規模（薬局、オンライン販売、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・豚丹毒ワクチンの世界市場概要 ・メーカー別の競争状況、市場シェア ・豚丹毒ワクチンの種類別市場規模：活性、非活性 ・豚丹毒ワクチンの用途別市場規模：薬局、オンライン販売、その他 ・北米の豚丹毒ワクチン市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの豚丹毒ワクチン市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの豚丹毒ワクチン市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の豚丹毒ワクチン市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの豚丹毒ワクチン市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Zoetis、Merck、Boehringer Ingelheim、Qilu Animal Health、CAHIC、Chengdu Tianbang Biology、Jiujiang Bomeilai Biological、Jilin Zhengye Biological、Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.、Hunan Zhong'an Biological Pharmaceutical Co., Ltd. ・豚丹毒ワクチンのバリューチェーン・販売チャネル分析 ・豚丹毒ワクチンの世界市場動向

Swine Erysipelas Vaccine is used to prevent swine erysipelas. For pigs after weaning, the immunization period is 6 months.

Market Analysis and Insights: Global Swine Erysipelas Vaccine Market
The global Swine Erysipelas Vaccine market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Swine Erysipelas Vaccine Scope and Segment
Swine Erysipelas Vaccine market is segmented by Type, and by Distribution Channel. Players, stakeholders, and other participants in the global Swine Erysipelas Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Distribution Channel for the period 2016-2027.

Segment by Type
Live
Inactivated

Segment by Distribution Channel
Pharmacy
Online Sale
Others

By Company
Zoetis
Merck
Boehringer Ingelheim
Qilu Animal Health
CAHIC
Chengdu Tianbang Biology
Jiujiang Bomeilai Biological
Jilin Zhengye Biological
Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
Hunan Zhong’an Biological Pharmaceutical Co., Ltd.

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Swine Erysipelas Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Swine Erysipelas Vaccine Market Size Growth Rate by Type
1.2.2 Live
1.2.3 Inactivated
1.3 Market by Distribution Channel
1.3.1 Global Swine Erysipelas Vaccine Market Size Growth Rate by Distribution Channel
1.3.2 Pharmacy
1.3.3 Online Sale
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Swine Erysipelas Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global Swine Erysipelas Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global Swine Erysipelas Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Swine Erysipelas Vaccine Regions by Sales
2.4.1 Global Top Swine Erysipelas Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top Swine Erysipelas Vaccine Regions by Sales (2022-2027)
2.5 Global Top Swine Erysipelas Vaccine Regions by Revenue
2.5.1 Global Top Swine Erysipelas Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top Swine Erysipelas Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Swine Erysipelas Vaccine Sales by Manufacturers
3.1.1 Global Top Swine Erysipelas Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Swine Erysipelas Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Swine Erysipelas Vaccine Sales in 2020
3.2 Global Swine Erysipelas Vaccine Revenue by Manufacturers
3.2.1 Global Top Swine Erysipelas Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Swine Erysipelas Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Swine Erysipelas Vaccine Revenue in 2020
3.3 Global Swine Erysipelas Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Swine Erysipelas Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Swine Erysipelas Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Swine Erysipelas Vaccine Sales by Type
4.1.1 Global Swine Erysipelas Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global Swine Erysipelas Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global Swine Erysipelas Vaccine Sales Market Share by Type (2016-2027)
4.2 Global Swine Erysipelas Vaccine Revenue by Type
4.2.1 Global Swine Erysipelas Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global Swine Erysipelas Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Swine Erysipelas Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global Swine Erysipelas Vaccine Price by Type
4.3.1 Global Swine Erysipelas Vaccine Price by Type (2016-2021)
4.3.2 Global Swine Erysipelas Vaccine Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Swine Erysipelas Vaccine Sales by Distribution Channel
5.1.1 Global Swine Erysipelas Vaccine Historical Sales by Distribution Channel (2016-2021)
5.1.2 Global Swine Erysipelas Vaccine Forecasted Sales by Distribution Channel (2022-2027)
5.1.3 Global Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2027)
5.2 Global Swine Erysipelas Vaccine Revenue by Distribution Channel
5.2.1 Global Swine Erysipelas Vaccine Historical Revenue by Distribution Channel (2016-2021)
5.2.2 Global Swine Erysipelas Vaccine Forecasted Revenue by Distribution Channel (2022-2027)
5.2.3 Global Swine Erysipelas Vaccine Revenue Market Share by Distribution Channel (2016-2027)
5.3 Global Swine Erysipelas Vaccine Price by Distribution Channel
5.3.1 Global Swine Erysipelas Vaccine Price by Distribution Channel (2016-2021)
5.3.2 Global Swine Erysipelas Vaccine Price Forecast by Distribution Channel (2022-2027)

6 North America
6.1 North America Swine Erysipelas Vaccine Market Size by Type
6.1.1 North America Swine Erysipelas Vaccine Sales by Type (2016-2027)
6.1.2 North America Swine Erysipelas Vaccine Revenue by Type (2016-2027)
6.2 North America Swine Erysipelas Vaccine Market Size by Distribution Channel
6.2.1 North America Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2027)
6.2.2 North America Swine Erysipelas Vaccine Revenue by Distribution Channel (2016-2027)
6.3 North America Swine Erysipelas Vaccine Market Size by Country
6.3.1 North America Swine Erysipelas Vaccine Sales by Country (2016-2027)
6.3.2 North America Swine Erysipelas Vaccine Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Swine Erysipelas Vaccine Market Size by Type
7.1.1 Europe Swine Erysipelas Vaccine Sales by Type (2016-2027)
7.1.2 Europe Swine Erysipelas Vaccine Revenue by Type (2016-2027)
7.2 Europe Swine Erysipelas Vaccine Market Size by Distribution Channel
7.2.1 Europe Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2027)
7.2.2 Europe Swine Erysipelas Vaccine Revenue by Distribution Channel (2016-2027)
7.3 Europe Swine Erysipelas Vaccine Market Size by Country
7.3.1 Europe Swine Erysipelas Vaccine Sales by Country (2016-2027)
7.3.2 Europe Swine Erysipelas Vaccine Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Swine Erysipelas Vaccine Market Size by Type
8.1.1 Asia Pacific Swine Erysipelas Vaccine Sales by Type (2016-2027)
8.1.2 Asia Pacific Swine Erysipelas Vaccine Revenue by Type (2016-2027)
8.2 Asia Pacific Swine Erysipelas Vaccine Market Size by Distribution Channel
8.2.1 Asia Pacific Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2027)
8.2.2 Asia Pacific Swine Erysipelas Vaccine Revenue by Distribution Channel (2016-2027)
8.3 Asia Pacific Swine Erysipelas Vaccine Market Size by Region
8.3.1 Asia Pacific Swine Erysipelas Vaccine Sales by Region (2016-2027)
8.3.2 Asia Pacific Swine Erysipelas Vaccine Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Swine Erysipelas Vaccine Market Size by Type
9.1.1 Latin America Swine Erysipelas Vaccine Sales by Type (2016-2027)
9.1.2 Latin America Swine Erysipelas Vaccine Revenue by Type (2016-2027)
9.2 Latin America Swine Erysipelas Vaccine Market Size by Distribution Channel
9.2.1 Latin America Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2027)
9.2.2 Latin America Swine Erysipelas Vaccine Revenue by Distribution Channel (2016-2027)
9.3 Latin America Swine Erysipelas Vaccine Market Size by Country
9.3.1 Latin America Swine Erysipelas Vaccine Sales by Country (2016-2027)
9.3.2 Latin America Swine Erysipelas Vaccine Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Swine Erysipelas Vaccine Market Size by Type
10.1.1 Middle East and Africa Swine Erysipelas Vaccine Sales by Type (2016-2027)
10.1.2 Middle East and Africa Swine Erysipelas Vaccine Revenue by Type (2016-2027)
10.2 Middle East and Africa Swine Erysipelas Vaccine Market Size by Distribution Channel
10.2.1 Middle East and Africa Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2027)
10.2.2 Middle East and Africa Swine Erysipelas Vaccine Revenue by Distribution Channel (2016-2027)
10.3 Middle East and Africa Swine Erysipelas Vaccine Market Size by Country
10.3.1 Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2016-2027)
10.3.2 Middle East and Africa Swine Erysipelas Vaccine Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Overview
11.1.3 Zoetis Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Zoetis Swine Erysipelas Vaccine Product Description
11.1.5 Zoetis Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Merck Swine Erysipelas Vaccine Product Description
11.2.5 Merck Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Boehringer Ingelheim Swine Erysipelas Vaccine Product Description
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Qilu Animal Health
11.4.1 Qilu Animal Health Corporation Information
11.4.2 Qilu Animal Health Overview
11.4.3 Qilu Animal Health Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Qilu Animal Health Swine Erysipelas Vaccine Product Description
11.4.5 Qilu Animal Health Recent Developments
11.5 CAHIC
11.5.1 CAHIC Corporation Information
11.5.2 CAHIC Overview
11.5.3 CAHIC Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 CAHIC Swine Erysipelas Vaccine Product Description
11.5.5 CAHIC Recent Developments
11.6 Chengdu Tianbang Biology
11.6.1 Chengdu Tianbang Biology Corporation Information
11.6.2 Chengdu Tianbang Biology Overview
11.6.3 Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Chengdu Tianbang Biology Swine Erysipelas Vaccine Product Description
11.6.5 Chengdu Tianbang Biology Recent Developments
11.7 Jiujiang Bomeilai Biological
11.7.1 Jiujiang Bomeilai Biological Corporation Information
11.7.2 Jiujiang Bomeilai Biological Overview
11.7.3 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product Description
11.7.5 Jiujiang Bomeilai Biological Recent Developments
11.8 Jilin Zhengye Biological
11.8.1 Jilin Zhengye Biological Corporation Information
11.8.2 Jilin Zhengye Biological Overview
11.8.3 Jilin Zhengye Biological Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Jilin Zhengye Biological Swine Erysipelas Vaccine Product Description
11.8.5 Jilin Zhengye Biological Recent Developments
11.9 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
11.9.1 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Corporation Information
11.9.2 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Overview
11.9.3 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product Description
11.9.5 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Developments
11.10 Hunan Zhong’an Biological Pharmaceutical Co., Ltd.
11.10.1 Hunan Zhong’an Biological Pharmaceutical Co., Ltd. Corporation Information
11.10.2 Hunan Zhong’an Biological Pharmaceutical Co., Ltd. Overview
11.10.3 Hunan Zhong’an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Hunan Zhong’an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product Description
11.10.5 Hunan Zhong’an Biological Pharmaceutical Co., Ltd. Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Swine Erysipelas Vaccine Value Chain Analysis
12.2 Swine Erysipelas Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Swine Erysipelas Vaccine Production Mode & Process
12.4 Swine Erysipelas Vaccine Sales and Marketing
12.4.1 Swine Erysipelas Vaccine Sales Channels
12.4.2 Swine Erysipelas Vaccine Distributors
12.5 Swine Erysipelas Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Swine Erysipelas Vaccine Industry Trends
13.2 Swine Erysipelas Vaccine Market Drivers
13.3 Swine Erysipelas Vaccine Market Challenges
13.4 Swine Erysipelas Vaccine Market Restraints

14 Key Findings in The Global Swine Erysipelas Vaccine Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Swine Erysipelas Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Live
Table 3. Major Manufacturers of Inactivated
Table 4. Global Swine Erysipelas Vaccine Market Size Growth Rate by Distribution Channel, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Swine Erysipelas Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Swine Erysipelas Vaccine Sales by Region (2016-2021) & (K Units)
Table 7. Global Swine Erysipelas Vaccine Sales Market Share by Region (2016-2021)
Table 8. Global Swine Erysipelas Vaccine Sales by Region (2022-2027) & (K Units)
Table 9. Global Swine Erysipelas Vaccine Sales Market Share by Region (2022-2027)
Table 10. Global Swine Erysipelas Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Swine Erysipelas Vaccine Revenue Market Share by Region (2016-2021)
Table 12. Global Swine Erysipelas Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Swine Erysipelas Vaccine Revenue Market Share by Region (2022-2027)
Table 14. Global Swine Erysipelas Vaccine Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Swine Erysipelas Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Global Swine Erysipelas Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Swine Erysipelas Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Swine Erysipelas Vaccine Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Swine Erysipelas Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Swine Erysipelas Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Erysipelas Vaccine as of 2020)
Table 21. Swine Erysipelas Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Swine Erysipelas Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Swine Erysipelas Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Swine Erysipelas Vaccine Sales by Type (2016-2021) & (K Units)
Table 26. Global Swine Erysipelas Vaccine Sales by Type (2022-2027) & (K Units)
Table 27. Global Swine Erysipelas Vaccine Sales Share by Type (2016-2021)
Table 28. Global Swine Erysipelas Vaccine Sales Share by Type (2022-2027)
Table 29. Global Swine Erysipelas Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Swine Erysipelas Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Swine Erysipelas Vaccine Revenue Share by Type (2016-2021)
Table 32. Global Swine Erysipelas Vaccine Revenue Share by Type (2022-2027)
Table 33. Swine Erysipelas Vaccine Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Swine Erysipelas Vaccine Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 36. Global Swine Erysipelas Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 37. Global Swine Erysipelas Vaccine Sales Share by Distribution Channel (2016-2021)
Table 38. Global Swine Erysipelas Vaccine Sales Share by Distribution Channel (2022-2027)
Table 39. Global Swine Erysipelas Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 40. Global Swine Erysipelas Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 41. Global Swine Erysipelas Vaccine Revenue Share by Distribution Channel (2016-2021)
Table 42. Global Swine Erysipelas Vaccine Revenue Share by Distribution Channel (2022-2027)
Table 43. Swine Erysipelas Vaccine Price by Distribution Channel (2016-2021) & (US$/Unit)
Table 44. Global Swine Erysipelas Vaccine Price Forecast by Distribution Channel (2022-2027) & (US$/Unit)
Table 45. North America Swine Erysipelas Vaccine Sales by Type (2016-2021) & (K Units)
Table 46. North America Swine Erysipelas Vaccine Sales by Type (2022-2027) & (K Units)
Table 47. North America Swine Erysipelas Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Swine Erysipelas Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 50. North America Swine Erysipelas Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 51. North America Swine Erysipelas Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 52. North America Swine Erysipelas Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 53. North America Swine Erysipelas Vaccine Sales by Country (2016-2021) & (K Units)
Table 54. North America Swine Erysipelas Vaccine Sales by Country (2022-2027) & (K Units)
Table 55. North America Swine Erysipelas Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Swine Erysipelas Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Swine Erysipelas Vaccine Sales by Type (2016-2021) & (K Units)
Table 58. Europe Swine Erysipelas Vaccine Sales by Type (2022-2027) & (K Units)
Table 59. Europe Swine Erysipelas Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Swine Erysipelas Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 62. Europe Swine Erysipelas Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 63. Europe Swine Erysipelas Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 64. Europe Swine Erysipelas Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 65. Europe Swine Erysipelas Vaccine Sales by Country (2016-2021) & (K Units)
Table 66. Europe Swine Erysipelas Vaccine Sales by Country (2022-2027) & (K Units)
Table 67. Europe Swine Erysipelas Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Swine Erysipelas Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Swine Erysipelas Vaccine Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Swine Erysipelas Vaccine Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Swine Erysipelas Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Swine Erysipelas Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 74. Asia Pacific Swine Erysipelas Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 75. Asia Pacific Swine Erysipelas Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 76. Asia Pacific Swine Erysipelas Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 77. Asia Pacific Swine Erysipelas Vaccine Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Swine Erysipelas Vaccine Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Swine Erysipelas Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Swine Erysipelas Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Swine Erysipelas Vaccine Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Swine Erysipelas Vaccine Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Swine Erysipelas Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Swine Erysipelas Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 86. Latin America Swine Erysipelas Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 87. Latin America Swine Erysipelas Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 88. Latin America Swine Erysipelas Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 89. Latin America Swine Erysipelas Vaccine Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Swine Erysipelas Vaccine Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Swine Erysipelas Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Swine Erysipelas Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Swine Erysipelas Vaccine Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Swine Erysipelas Vaccine Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Swine Erysipelas Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Swine Erysipelas Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 98. Middle East and Africa Swine Erysipelas Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 99. Middle East and Africa Swine Erysipelas Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Swine Erysipelas Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Swine Erysipelas Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Swine Erysipelas Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 105. Zoetis Corporation Information
Table 106. Zoetis Description and Major Businesses
Table 107. Zoetis Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Zoetis Swine Erysipelas Vaccine Product
Table 109. Zoetis Recent Developments
Table 110. Merck Corporation Information
Table 111. Merck Description and Major Businesses
Table 112. Merck Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Merck Swine Erysipelas Vaccine Product
Table 114. Merck Recent Developments
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Major Businesses
Table 117. Boehringer Ingelheim Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Boehringer Ingelheim Swine Erysipelas Vaccine Product
Table 119. Boehringer Ingelheim Recent Developments
Table 120. Qilu Animal Health Corporation Information
Table 121. Qilu Animal Health Description and Major Businesses
Table 122. Qilu Animal Health Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Qilu Animal Health Swine Erysipelas Vaccine Product
Table 124. Qilu Animal Health Recent Developments
Table 125. CAHIC Corporation Information
Table 126. CAHIC Description and Major Businesses
Table 127. CAHIC Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. CAHIC Swine Erysipelas Vaccine Product
Table 129. CAHIC Recent Developments
Table 130. Chengdu Tianbang Biology Corporation Information
Table 131. Chengdu Tianbang Biology Description and Major Businesses
Table 132. Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Chengdu Tianbang Biology Swine Erysipelas Vaccine Product
Table 134. Chengdu Tianbang Biology Recent Developments
Table 135. Jiujiang Bomeilai Biological Corporation Information
Table 136. Jiujiang Bomeilai Biological Description and Major Businesses
Table 137. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product
Table 139. Jiujiang Bomeilai Biological Recent Developments
Table 140. Jilin Zhengye Biological Corporation Information
Table 141. Jilin Zhengye Biological Description and Major Businesses
Table 142. Jilin Zhengye Biological Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Jilin Zhengye Biological Swine Erysipelas Vaccine Product
Table 144. Jilin Zhengye Biological Recent Developments
Table 145. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Corporation Information
Table 146. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Description and Major Businesses
Table 147. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 148. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product
Table 149. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Developments
Table 150. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Corporation Information
Table 151. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Description and Major Businesses
Table 152. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 153. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product
Table 154. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Swine Erysipelas Vaccine Distributors List
Table 158. Swine Erysipelas Vaccine Customers List
Table 159. Swine Erysipelas Vaccine Market Trends
Table 160. Swine Erysipelas Vaccine Market Drivers
Table 161. Swine Erysipelas Vaccine Market Challenges
Table 162. Swine Erysipelas Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Erysipelas Vaccine Product Picture
Figure 2. Global Swine Erysipelas Vaccine Market Share by Type in 2020 & 2027
Figure 3. Live Product Picture
Figure 4. Inactivated Product Picture
Figure 5. Global Swine Erysipelas Vaccine Market Share by Distribution Channel in 2020 & 2027
Figure 6. Pharmacy
Figure 7. Online Sale
Figure 8. Others
Figure 9. Swine Erysipelas Vaccine Report Years Considered
Figure 10. Global Swine Erysipelas Vaccine Sales 2016-2027 (K Units)
Figure 11. Global Swine Erysipelas Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Swine Erysipelas Vaccine Revenue 2016-2027 (US$ Million)
Figure 13. Global Swine Erysipelas Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Swine Erysipelas Vaccine Sales Market Share by Region (2016-2021)
Figure 15. Global Swine Erysipelas Vaccine Sales Market Share by Region (2022-2027)
Figure 16. North America Swine Erysipelas Vaccine Sales YoY (2016-2027) & (K Units)
Figure 17. North America Swine Erysipelas Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Swine Erysipelas Vaccine Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Swine Erysipelas Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Swine Erysipelas Vaccine Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Swine Erysipelas Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Swine Erysipelas Vaccine Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Swine Erysipelas Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Swine Erysipelas Vaccine Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Swine Erysipelas Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Swine Erysipelas Vaccine Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Swine Erysipelas Vaccine Revenue in 2020
Figure 28. Swine Erysipelas Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Swine Erysipelas Vaccine Sales Market Share by Type (2016-2027)
Figure 30. Global Swine Erysipelas Vaccine Revenue Market Share by Type (2016-2027)
Figure 31. Global Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 32. Global Swine Erysipelas Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 33. North America Swine Erysipelas Vaccine Sales Market Share by Type (2016-2027)
Figure 34. North America Swine Erysipelas Vaccine Revenue Market Share by Type (2016-2027)
Figure 35. North America Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 36. North America Swine Erysipelas Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 37. North America Swine Erysipelas Vaccine Sales Share by Country (2016-2027)
Figure 38. North America Swine Erysipelas Vaccine Revenue Share by Country (2016-2027)
Figure 39. United States Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Swine Erysipelas Vaccine Sales Market Share by Type (2016-2027)
Figure 42. Europe Swine Erysipelas Vaccine Revenue Market Share by Type (2016-2027)
Figure 43. Europe Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 44. Europe Swine Erysipelas Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 45. Europe Swine Erysipelas Vaccine Sales Share by Country (2016-2027)
Figure 46. Europe Swine Erysipelas Vaccine Revenue Share by Country (2016-2027)
Figure 47. Germany Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 48. France Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Swine Erysipelas Vaccine Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Swine Erysipelas Vaccine Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 55. Asia Pacific Swine Erysipelas Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 56. Asia Pacific Swine Erysipelas Vaccine Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Swine Erysipelas Vaccine Revenue Share by Region (2016-2027)
Figure 58. China Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 61. India Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Swine Erysipelas Vaccine Sales Market Share by Type (2016-2027)
Figure 68. Latin America Swine Erysipelas Vaccine Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 70. Latin America Swine Erysipelas Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 71. Latin America Swine Erysipelas Vaccine Sales Share by Country (2016-2027)
Figure 72. Latin America Swine Erysipelas Vaccine Revenue Share by Country (2016-2027)
Figure 73. Mexico Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Swine Erysipelas Vaccine Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 80. Middle East and Africa Swine Erysipelas Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 81. Middle East and Africa Swine Erysipelas Vaccine Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Swine Erysipelas Vaccine Revenue Share by Country (2016-2027)
Figure 83. Turkey Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Swine Erysipelas Vaccine Revenue (2016-2027) & (US$ Million)
Figure 86. Swine Erysipelas Vaccine Value Chain
Figure 87. Swine Erysipelas Vaccine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---